Presidential Communications Operations Office

  PIA Bldg, Visayas Ave, Diliman, Quezon City, Philippines
  Monday, 23 July 2018 News Before 1 Feb 2012. Click for Latest
Web PIA  
 << July 2018 >> 
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31
Special News Editions:
PIA Specials:
NEW! Cabinet Officials
Jobs.Slides.Specials.Ads. Events.ASEAN.Multimedia
Visitors since 15 Feb 2011:
PIA News Archive:
PIA Archive News Reader

PIA Press Release

DOH holds last IRR hearing for Cheaper Medicines Act

By Mai Gevera

Davao City (1 November) -- The last leg prior to implementation of the Cheaper Medicine Act or RA 9502 was held in Davao City and the Health Department is set to finalize the implementing rules by November 4.

The Universally Accessible Cheaper and Quality Medicines Act of 2008 had faced a lot of objections especially from the medical and pharmacological industry. However, Health Undersecretary Alexander Padilla confirmed that the law is now all set to be implemented.

The most controversial portion of the bill contested by many is the power given to the President to impose maximum retail prices over any or all drugs and medicines listed in the bill.

Some sectors debated that MRP or maximum retail price should not be imposed anytime and that the country should just let the market dictate the price of medicines.

"But we must always go back to the very intention of the law to bring down medicine prices for the poor," Padilla said.

The DOH sticks to the intention of coming out with a social legislation to regulate medicine prices which had been ultimately maneuvered by big drug companies.

The law states that the health secretary is authorized to establish and initiate a price monitoring and regulation system. The secretary should also recommend the MRP considering the retail prices of drugs, supply available in the market, cost to the manufacturer, importer, trader, distributor etc.

This provision prohibits retailers to sell drugs and medicines at a retail price exceeding the MRP approved by the President.

This would also push drug companies to produce and submit some pertinent records like input documents, records of purchase and sale, financial statements that would help the health secretary determine the appropriate MRP to be recommended to the President.

Padilla also bared that the DOH will come up with a list of drugs and their respective MRPs 15 days after the deadline which is on November 4. (PIA) [top]

|«  prev  next  »|
»New gov't? Wait until 2010, Davao Norte gov says
»Commentary: Electronic security devices in banks
»DOH holds last IRR hearing for Cheaper Medicines Act
»Employment Kiosk now in Davao Norte
»Gov. Uy: No localized peace talks with ComVal rebs
»ComVal gov delivers 2nd local state-of-the-children report
»ComVal to ban unlicensed 'hilots'
»Davao Light turns over 3rd school building
»Mindanao youth gather for peace
»New branches, ATMs machines for ONB in 2009
|«  prev  next  »|

Philippine Official Gazette | Office of the President | Presidential Communications Operations Office
For comments and feedback, please email PIA Newsdesk
Copyright © 2005 Philippine Information Agency
PIA Building, Visayas Avenue, Diliman, Quezon City 1101 Philippines